Yahoo Web Search

Search results

    • Tharimmune Announces 1-for-15 Reverse Stock Split

      Morningstar· 3 hours ago

      (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced ...